Cognitive decline with age is natural. While many people over 50 are turning to cognitive activities like chess and sudoku, ...
Mindset-wise, what sets me—an ordinary athlete—apart from an Olympic champion? Or, if comparing myself to an Olympian is like ...
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic ...
New research in mice has shown that different doses of psilocybin engage the brain's 5-HT2A receptors to varying degrees, producing distinct behavioral and neuroplastic effects. Moderate doses reduced ...
Enveric Biosciences Inc. ENVB on Tuesday highlighted preclinical findings for its lead candidate EB-003. It pointed to rapid ...
As young men pursue radical methods of “looksmaxxing,” young women are discovering a world of YouTube and TikTok videos that ...
The inclusion of ibogaine in a recent executive order from President Donald Trump marks a notable moment in the evolving ...
Research and policy changes are driving new interest in psychedelic treatments like psilocybin for mental health conditions.
Catholic Mental Health Professionals React to Executive Order Removing Barriers to Psychedelic Drugs
The executive order notes that more than 14 million American adults now suffer from serious mental illness, a large rise from ...
Neuroscience expert Anaïs Rous explains the secrets of neuroplasticity, the gut-brain axis, and why "training" your brain is ...
Federal directives deploy priority review vouchers, earlier DEA rescheduling, and ARPA-H matching funds to compress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results